I’ve been keeping an eye on TEM lately. Could this be a growth stock in the AI healthcare sector?

First and foremost, the company is still operating at a loss, but its revenue growth momentum is very strong (according to the latest filings, the most recent year over year growth rate is approximately 70%–80%). The business operates at the intersection of artificial intelligence and healthcare data, focusing primarily on precision medicine and large scale clinical datasets.

However, after a strong rally following its initial public offering (IPO), TEM is currently stabilizing. The price action has been range bound for over a month, with support repeatedly forming in the $40 plus range and resistance forming just below $60. At this point, this appears to be more of a potential accumulation phase than a downtrend, but an increase in trading volume is needed to confirm a successful breakout. Overall, I believe this is a high risk but high growth healthcare company with long term potential, though it is not... Curious to hear what others think about this? Especially those following Al Healthcare or biotech data platforms.